gene

MYC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MYC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2227Connections
1Hypotheses
0Analyses
50Outgoing
50Incoming
0Experiments
0Debates

Summary

MYC is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 1388 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolMYC
Chromosome8q24.21
Functionis an important component in the neurobiology of neurodegenerative diseases.
Exons3
PathwaysAkt, Amyloid, Angiogenesis, Apoptosis, Autophagy
Ensembl IDENSG00000136997
GeneCardsMYC
Human Protein AtlasMYC
Associated DiseasesAging, Als, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis
Known Drugs/CompoundsBazhen Decoction, COENZYME Q10, LWDHD, MYC inhibitors, rapamycin, RAPAMYCIN
Interactions66CTG peptide, ABCD1, ABCD2, ABL1, ACETYL-COA, ACHE
KG Connections2227 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

MYC Gene

gene · 759 words

Pathway Diagram

graph TD
    MYC["MYC
(Central Gene)"] STAT3["STAT3"] PINK1["PINK1"] Cancer["Cancer"] Carcinoma["Carcinoma"] Lymphoma["Lymphoma"] Tumor["Tumor"] MetabolicSyndrome["Metabolic Syndrome"] Ms["Ms"] Als["Als"] Ischemia["Ischemia"] STAT3 -->|"regulates"| MYC MYC -->|"activates"| PINK1 MYC -->|"activates"| Cancer MYC -->|"activates"| MetabolicSyndrome MYC -->|"activates"| Ms MYC -->|"activates"| Als MYC -->|"activates"| Tumor MYC -->|"regulates"| Ischemia MYC -->|"regulates"| Cancer MYC -->|"associated_with"| Cancer MYC -->|"associated_with"| Carcinoma MYC -->|"associated_with"| Lymphoma MYC -->|"associated_with"| Tumor MYC -->|"therapeutic_target"| Cancer style MYC fill:#ff6b6b,stroke:#c92a2a,stroke-width:3px,color:#e0e0e0,font-size:14px style Cancer fill:#ffd43b,stroke:#f59f00,stroke-width:2px style Tumor fill:#ffd43b,stroke:#f59f00,stroke-width:2px style Lymphoma fill:#ffd43b,stroke:#f59f00,stroke-width:2px style Carcinoma fill:#ffd43b,stroke:#f59f00,stroke-width:2px

Outgoing (1341)

TargetRelationTypeStr
Tumortherapeutic_targetdisease1.00
Alstherapeutic_targetdisease1.00
Cancertherapeutic_targetdisease1.00
Cancerassociated_withdisease1.00
Cancerexpressed_indisease1.00

Incoming (886)

SourceRelationTypeStr
AKTactivatesgene1.00
CANCERactivatesgene1.00
CANCERassociated_withgene1.00
INFLAMMATIONactivatesgene1.00
APOPTOSISactivatesgene1.00

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Transient OCT4/SOX2/KLF4/c-MYC Expression Reverses Epigeneti 0.540 neurodegeneration epigenetic reprogramming aging neurons

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity